Plain-English translation of NCT07435662 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Heart Failure research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a specialized approach to heart failure care works better than usual care for patients with limited access to healthcare. Some patients will receive extra visits with a pharmacist who helps adjust their medications and provides education materials, while others will receive standard heart failure care. The goal is to see if this approach helps patients take their heart failure medications at higher, more effective doses.
Many patients with heart failure aren't taking their medications at the full doses proven to help them live longer and avoid hospitalization. This trial wants to see if pharmacist-led education and medication adjustment visits can help patients with limited healthcare access get the same benefits that better-served populations already receive.
You likely qualify if…
You likely don't qualify if…
If you join, you'll be randomly assigned to one of two groups. One group will have regular heart failure visits plus extra appointments with a pharmacist who will review and adjust your medications and give you educational materials. The other group will continue with their usual heart failure care. The study will track how many medication adjustments happen and measure how close you are getting to the recommended medication doses for heart failure.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
United States